AGEN today
$6.73-$0.14 (-2.04%)close Nov 13, 2026Trend
DailyDowntrend (starting)
4 hourDescending Triangle
1 hourStrong Bearish
15 minStrong Bearish
5 minStrong Bullish
Daily trend turns up above $10.31
Key levels
Resistance$8.16
Resistance$7.30
Support$6.70
Support$6.11
Latest news & SEC filings
AnalystB. Riley Securities keeps Agenus at Buy, lifts price target
AnalystB. Riley Securities kept its Buy rating on Agenus (AGEN) and raised its price target to $16 from $14.
ProductAgenus shares long-term survivor results for botensilimab plus balstilimab in pretreated MSS mCRC
All AGEN news →About Agenus
Agenus is a biotechnology company that develops immunotherapies for cancer and autoimmune diseases. Its pipeline includes antibody-based product candidates and other biologic treatments intended to activate the immune system. The company depends on outside manufacturers and partners for production and development work. Its operations are based in the United States.
Based on the company's 10-K filed Mar 16, 2026.
Nasdaq · Healthcare
AGENUS INC (AGEN)
What Is the Price Target for AGEN?
SEPT Low Target
$14.00
SEPT Mid Target
$19.00
SEPT High Target
$40.00
Analyst Consensus
$19.00
Is AGEN a Buy or Sell Right Now?
Thesis
- •Revenue growing 10.4% YoY with STABLE trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for AGEN.
Start Free Trial →Is AGEN Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, PEG, Analyst Consensus
Fair Value
$14.03
25
Moat Score
NONE
3/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with AGEN?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| ARMEN GARO H | director officer | Buy | 4,852 | $16K | Jul 10, 2026 |
| ARMEN GARO H | director officer | Buy | 4,644 | $16K | May 29, 2026 |
| ARMEN GARO H | director officer | Buy | 4,540 | $16K | May 15, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →AGEN Growth Story
Revenue YoY
10.4%
3yr Revenue CAGR
5.2%
EPS Growth YoY
100%
FCF Growth YoY
51.4%
Revenue Trend
STABLE
Dark Pool Trades for AGEN
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for AGEN, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 18:40:23 | $6.75 | 1,000 | $$7K | BUY |
| 16:55:19 | $6.75 | 2,044 | $$14K | MIDPOINT |
| 16:15:27 | $6.63 | 1,080 | $$7K | SELL |
| 16:12:10 | $6.65 | 1,000 | $$7K | BUY |
| 16:10:50 | $6.61 | 1,000 | $$7K | SELL |
5 dark pool trades shown · $$41K preview volume
Real-time institutional flow, block trades, and net positioning
What Traders Are Saying About AGEN
1 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for AGEN. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
Zone Setup -- $AGEN (AGENUS INC) Price: $5.01 | Zone: $4.66 to $8.70 Conviction: HIGH | Analyst upside: +500% Near support (9% of range) — reversal watch. Strong positive news (2+ vs 0-). Analyst ta...
Join 3,500+ traders discussing AGEN in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for AGENUS INC (AGEN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →AGEN — frequently asked questions
What is AGEN stock price today?
AGENUS INC (AGEN) is at $6.73, down 2.04% (-$0.14) at the Nov 13, 2026 close.
Why is AGEN stock moving today?
Latest AGEN news — Nov 9, 2026: B. Riley Securities keeps Agenus at Buy, lifts price target · Nov 9, 2026: B. Riley Securities kept its Buy rating on Agenus (AGEN) and raised its price target to $16 from $14.
What is the AGEN price target?
The average analyst price target for AGEN is $19.00, ranging from $14 to $40, based on 6 analysts.
What do analysts rate AGEN?
Analyst ratings for AGEN: 2 Buy, 4 Hold, 0 Sell — consensus Hold.
Did AGEN beat earnings?
AGEN last reported on Nov 5, 2026: EPS -$0.18 vs -$0.28 expected — a beat of 36.3%.
What is AGEN's P/E ratio?
AGEN trades at a P/E of 6.6 vs a Healthcare average of 17.3.
Does AGEN pay a dividend?
AGEN does not currently pay a dividend.
How much debt does AGEN have?
AGENUS INC reported $30M of debt and $67M of cash (Sep 30, 2026).
What are AGEN support and resistance levels?
Support: $6.70, $6.11, $4.66. Resistance: $7.30, $8.16, $8.82.
What are insiders doing with AGEN?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on AGEN?
Nov 9, 2026: B. Riley Securities keeps Agenus at Buy, lifts price target · Nov 9, 2026: B. Riley Securities kept its Buy rating on Agenus (AGEN) and raised its price target to $16 from $14. · Nov 6, 2026: Agenus shares long-term survivor results for botensilimab plus balstilimab in pretreated MSS mCRC